Current Protein Identity:P58154 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1I9B X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) Deposited 2001-03-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa)
Chain B 21–229(209 aa)
Chain C 21–229(209 aa)
Chain D 21–229(209 aa)
Chain E 21–229(209 aa)
Mutation:L1F Mutation:L1F Mutation:L1F Mutation:L1F Mutation:L1F CA CALCIUM ION × 8 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;PEG 4000, CALCIUM CHLORIDE, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295.0K
Resolution 2.70 Å R-free 0.297
1I9B X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) Deposited 2001-03-18 Assembly 2 Protein homooligomer Homooligomer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 21–229(209 aa)
Chain B 21–229(209 aa)
Chain C 21–229(209 aa)
Chain D 21–229(209 aa)
Chain E 21–229(209 aa)
Mutation:L1F Mutation:L1F Mutation:L1F Mutation:L1F Mutation:L1F CA CALCIUM ION × 16 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 10 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;PEG 4000, CALCIUM CHLORIDE, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295.0K
Resolution 2.70 Å R-free 0.297
1UV6 X-ray structure of acetylcholine binding protein (AChBP) in complex with carbamylcholine Deposited 2004-01-15 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded CCE 2-[(AMINOCARBONYL)OXY]-N,N,N-TRIMETHYLETHANAMINIUM × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;CAPS PH 10.5, AMMONIUM SULFATE
Resolution 2.50 Å R-free 0.265
1UV6 X-ray structure of acetylcholine binding protein (AChBP) in complex with carbamylcholine Deposited 2004-01-15 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded CCE 2-[(AMINOCARBONYL)OXY]-N,N,N-TRIMETHYLETHANAMINIUM × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;CAPS PH 10.5, AMMONIUM SULFATE
Resolution 2.50 Å R-free 0.265
1UW6 X-ray structure of acetylcholine binding protein (AChBP) in complex with nicotine Deposited 2004-01-30 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 19–229(211 aa)
Chain B 19–229(211 aa)
Chain C 19–229(211 aa)
Chain D 19–229(211 aa)
Chain E 19–229(211 aa)
Not recorded NCT (S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;TRIS PH 8.0, AMMONIUM SULFATE
Resolution 2.20 Å R-free 0.265
1UW6 X-ray structure of acetylcholine binding protein (AChBP) in complex with nicotine Deposited 2004-01-30 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 19–229(211 aa)
Chain G 19–229(211 aa)
Chain H 19–229(211 aa)
Chain I 19–229(211 aa)
Chain J 19–229(211 aa)
Not recorded NCT (S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;TRIS PH 8.0, AMMONIUM SULFATE
Resolution 2.20 Å R-free 0.265
1UW6 X-ray structure of acetylcholine binding protein (AChBP) in complex with nicotine Deposited 2004-01-30 Assembly 3 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain K 19–229(211 aa)
Chain L 19–229(211 aa)
Chain M 19–229(211 aa)
Chain N 19–229(211 aa)
Chain O 19–229(211 aa)
Not recorded NCT (S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;TRIS PH 8.0, AMMONIUM SULFATE
Resolution 2.20 Å R-free 0.265
1UW6 X-ray structure of acetylcholine binding protein (AChBP) in complex with nicotine Deposited 2004-01-30 Assembly 4 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain P 19–229(211 aa)
Chain Q 19–229(211 aa)
Chain R 19–229(211 aa)
Chain S 19–229(211 aa)
Chain T 19–229(211 aa)
Not recorded NCT (S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;TRIS PH 8.0, AMMONIUM SULFATE
Resolution 2.20 Å R-free 0.265
1UX2 X-ray structure of acetylcholine binding protein (AChBP) Deposited 2004-02-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 18–229(212 aa)
Chain B 18–229(212 aa)
Chain C 18–229(212 aa)
Chain D 18–229(212 aa)
Chain E 18–229(212 aa)
Not recorded EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 SO4 SULFATE ION × 1 NH4 AMMONIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;TRIS PH 8.0, AMMONIUM SULFATE
Resolution 2.20 Å R-free 0.284
1UX2 X-ray structure of acetylcholine binding protein (AChBP) Deposited 2004-02-18 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 18–229(212 aa)
Chain G 18–229(212 aa)
Chain H 18–229(212 aa)
Chain I 18–229(212 aa)
Chain J 18–229(212 aa)
Not recorded EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 SO4 SULFATE ION × 1 NH4 AMMONIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;TRIS PH 8.0, AMMONIUM SULFATE
Resolution 2.20 Å R-free 0.284
1YI5 Crystal structure of the a-cobratoxin-AChBP complex Deposited 2005-01-11 Assembly 1 Protein heterocomplex Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;0.9M NA-CITRATE, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 4.20 Å R-free 0.378
2ZJU Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein (Ls-AChBP) Complexed with Imidacloprid Deposited 2008-03-10 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 16–229(214 aa) Fragment:UNP residues 16-229
Chain B 16–229(214 aa) Fragment:UNP residues 16-229
Chain C 16–229(214 aa) Fragment:UNP residues 16-229
Chain D 16–229(214 aa) Fragment:UNP residues 16-229
Chain E 16–229(214 aa) Fragment:UNP residues 16-229
Mutation:S0A, L1A, N66D Mutation:S0A, L1A, N66D Mutation:S0A, L1A, N66D Mutation:S0A, L1A, N66D Mutation:S0A, L1A, N66D IM4 (2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.7;293 K;0.2M Na citrate, pH5.7, 15-22% PEG3350, 0.5mM imidacloprid, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K
Resolution 2.58 Å R-free 0.277
2ZJV Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein (Ls-AChBP) Complexed with Clothianidin Deposited 2008-03-10 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 16–229(214 aa) Fragment:UNP residues 16-229
Chain B 16–229(214 aa) Fragment:UNP residues 16-229
Chain C 16–229(214 aa) Fragment:UNP residues 16-229
Chain D 16–229(214 aa) Fragment:UNP residues 16-229
Chain E 16–229(214 aa) Fragment:UNP residues 16-229
Mutation:S0A, L1A, N66D Mutation:S0A, L1A, N66D Mutation:S0A, L1A, N66D Mutation:S0A, L1A, N66D Mutation:S0A, L1A, N66D CT4 1-[(2-chloro-1,3-thiazol-5-yl)methyl]-3-methyl-2-nitroguanidine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.7;293 K;0.2M Na citrate, pH5.7, 15-22% PEG3350, 0.5mM clothianidin, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.70 Å R-free 0.270
3U8J Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3531 (1-(pyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded 09O 1-(pyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 1.9M Ammonium sulfate, 1% PEG 400, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.35 Å R-free 0.258
3U8J Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3531 (1-(pyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded 09O 1-(pyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 2 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 1.9M Ammonium sulfate, 1% PEG 400, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.35 Å R-free 0.258
3U8K Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3573 (1-(5-ethoxypyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded 09P 1-(5-ethoxypyridin-3-yl)-1,4-diazepane × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 2.0M Ammonium sulfate, 2% PEG 400, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.47 Å R-free 0.236
3U8K Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3573 (1-(5-ethoxypyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded 09P 1-(5-ethoxypyridin-3-yl)-1,4-diazepane × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 2.0M Ammonium sulfate, 2% PEG 400, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.47 Å R-free 0.236
3U8K Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3573 (1-(5-ethoxypyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 3 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain K 20–229(210 aa)
Chain L 20–229(210 aa)
Chain M 20–229(210 aa)
Chain N 20–229(210 aa)
Chain O 20–229(210 aa)
Not recorded 09P 1-(5-ethoxypyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 2.0M Ammonium sulfate, 2% PEG 400, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.47 Å R-free 0.236
3U8K Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3573 (1-(5-ethoxypyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 4 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain P 20–229(210 aa)
Chain Q 20–229(210 aa)
Chain R 20–229(210 aa)
Chain S 20–229(210 aa)
Chain T 20–229(210 aa)
Not recorded 09P 1-(5-ethoxypyridin-3-yl)-1,4-diazepane × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 2.0M Ammonium sulfate, 2% PEG 400, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.47 Å R-free 0.236
3U8L Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3570 (1-(5-phenylpyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded 09Q 1-(5-phenylpyridin-3-yl)-1,4-diazepane × 7 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;50mM Tris, 1.5M Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.32 Å R-free 0.244
3U8L Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3570 (1-(5-phenylpyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded 09Q 1-(5-phenylpyridin-3-yl)-1,4-diazepane × 7 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;50mM Tris, 1.5M Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.32 Å R-free 0.244
3U8M Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3920 (1-(6-bromopyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 1.9M Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.70 Å R-free 0.275
3U8M Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3920 (1-(6-bromopyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 1.9M Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.70 Å R-free 0.275
3U8M Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3920 (1-(6-bromopyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 3 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain K 20–229(210 aa)
Chain L 20–229(210 aa)
Chain M 20–229(210 aa)
Chain N 20–229(210 aa)
Chain O 20–229(210 aa)
Not recorded 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 1.9M Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.70 Å R-free 0.275
3U8M Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3920 (1-(6-bromopyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 4 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain P 20–229(210 aa)
Chain Q 20–229(210 aa)
Chain R 20–229(210 aa)
Chain S 20–229(210 aa)
Chain T 20–229(210 aa)
Not recorded 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 1.9M Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.70 Å R-free 0.275
3U8N Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3950 (1-(6-bromo-5-ethoxypyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded 09S 1-(6-bromo-5-ethoxypyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 1.9 M Ammonium sulfate, 3% PEG 400, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.35 Å R-free 0.230
3U8N Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3950 (1-(6-bromo-5-ethoxypyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded 09S 1-(6-bromo-5-ethoxypyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 1.9 M Ammonium sulfate, 3% PEG 400, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.35 Å R-free 0.230
3U8N Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3950 (1-(6-bromo-5-ethoxypyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 3 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain K 20–229(210 aa)
Chain L 20–229(210 aa)
Chain M 20–229(210 aa)
Chain N 20–229(210 aa)
Chain O 20–229(210 aa)
Not recorded 09S 1-(6-bromo-5-ethoxypyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 1.9 M Ammonium sulfate, 3% PEG 400, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.35 Å R-free 0.230
3U8N Crystal structure of the acetylcholine binding protein (AChBP) from Lymnaea stagnalis in complex with NS3950 (1-(6-bromo-5-ethoxypyridin-3-yl)-1,4-diazepane) Deposited 2011-10-17 Assembly 4 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain P 20–229(210 aa)
Chain Q 20–229(210 aa)
Chain R 20–229(210 aa)
Chain S 20–229(210 aa)
Chain T 20–229(210 aa)
Not recorded 09S 1-(6-bromo-5-ethoxypyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 3 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;50mM Tris, 1.9 M Ammonium sulfate, 3% PEG 400, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.35 Å R-free 0.230
3WIP Crystal structure of acetylcholine bound to Ls-AChBP Deposited 2013-09-24 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–229(229 aa)
Chain B 1–229(229 aa)
Chain C 1–229(229 aa)
Chain D 1–229(229 aa)
Chain E 1–229(229 aa)
Not recorded ACH ACETYLCHOLINE × 5 1PE PENTAETHYLENE GLYCOL × 8 SO4 SULFATE ION × 4 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1M TRIS, 1.025M (NH4)2SO4, 0.1M NaCl, 1.5% PEG 400, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.60 Å R-free 0.239
3WIP Crystal structure of acetylcholine bound to Ls-AChBP Deposited 2013-09-24 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 1–229(229 aa)
Chain G 1–229(229 aa)
Chain H 1–229(229 aa)
Chain I 1–229(229 aa)
Chain J 1–229(229 aa)
Not recorded ACH ACETYLCHOLINE × 5 1PE PENTAETHYLENE GLYCOL × 4 SO4 SULFATE ION × 3 ACT ACETATE ION × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1M TRIS, 1.025M (NH4)2SO4, 0.1M NaCl, 1.5% PEG 400, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.60 Å R-free 0.239
3WTH Crystal Structure of Lymnaea stagnalis Acetylcholine-Binding Protein Q55R Mutant Complexed with Imidacloprid Deposited 2014-04-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa) Fragment:UNP residues 21-229
Chain B 21–229(209 aa) Fragment:UNP residues 21-229
Chain C 21–229(209 aa) Fragment:UNP residues 21-229
Chain D 21–229(209 aa) Fragment:UNP residues 21-229
Chain E 21–229(209 aa) Fragment:UNP residues 21-229
Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R IM4 (2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 5.7;293 K;0.2M Na citrate pH 5.7, 15-22% PEG3350, 0.5mM imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.54 Å R-free 0.271
3WTI Crystal Structure of Lymnaea stagnalis Acetylcholine-Binding Protein Q55R Mutant Complexed with Clothianidin Deposited 2014-04-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa) Fragment:UNP residues 21-229
Chain B 21–229(209 aa) Fragment:UNP residues 21-229
Chain C 21–229(209 aa) Fragment:UNP residues 21-229
Chain D 21–229(209 aa) Fragment:UNP residues 21-229
Chain E 21–229(209 aa) Fragment:UNP residues 21-229
Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R CT4 1-[(2-chloro-1,3-thiazol-5-yl)methyl]-3-methyl-2-nitroguanidine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 5.7;293 K;0.2M Na citrate pH 5.7, 15-22% PEG3350, 0.5mM clothianidin, VAPOR DIFFUSION, temperature 293K
Resolution 2.68 Å R-free 0.294
3WTJ Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Thiacloprid Deposited 2014-04-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa)
Chain B 21–229(209 aa)
Chain C 21–229(209 aa)
Chain D 21–229(209 aa)
Chain E 21–229(209 aa)
Not recorded TH4 {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 5.7;293 K;0.2M Na citrate pH 5.7, 15-22% PEG3350, 0.5mM thiacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.24 Å R-free 0.266
3WTK Crystal Structure of Lymnaea stagnalis Acetylcholine-Binding Protein Q55R Mutant Complexed with Thiacloprid Deposited 2014-04-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa) Fragment:UNP residues 21-229
Chain B 21–229(209 aa) Fragment:UNP residues 21-229
Chain C 21–229(209 aa) Fragment:UNP residues 21-229
Chain D 21–229(209 aa) Fragment:UNP residues 21-229
Chain E 21–229(209 aa) Fragment:UNP residues 21-229
Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R TH4 {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 5.7;293 K;0.2M Na citrate pH 5.7, 15-22% PEG3350, 0.5mM thiacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.69 Å R-free 0.274
3WTL Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Nitromethylene Analogue of Imidacloprid Deposited 2014-04-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa) Fragment:UNP residues 21-229
Chain B 21–229(209 aa) Fragment:UNP residues 21-229
Chain C 21–229(209 aa) Fragment:UNP residues 21-229
Chain D 21–229(209 aa) Fragment:UNP residues 21-229
Chain E 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N1Y 2-chloro-5-{[(2E)-2-(nitromethylidene)imidazolidin-1-yl]methyl}pyridine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 5.7;293 K;0.2M Na citrate pH 5.7, 15-22% PEG3350, 0.5mM Nitromethylene Analogue of Imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.30 Å R-free 0.265
3WTM Crystal Structure of Lymnaea stagnalis Acetylcholine-Binding Protein Q55R Mutant Complexed with Nitromethylene Analogue of Imidacloprid Deposited 2014-04-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa) Fragment:UNP residues 21-229
Chain B 21–229(209 aa) Fragment:UNP residues 21-229
Chain C 21–229(209 aa) Fragment:UNP residues 21-229
Chain D 21–229(209 aa) Fragment:UNP residues 21-229
Chain E 21–229(209 aa) Fragment:UNP residues 21-229
Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R N1Y 2-chloro-5-{[(2E)-2-(nitromethylidene)imidazolidin-1-yl]methyl}pyridine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.7;293 K;0.2M Na citrate pH 5.7, 15-22% PEG3350, 0.5mM Nitromethylene Analogue of Imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.48 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa) Fragment:UNP residues 21-229
Chain B 21–229(209 aa) Fragment:UNP residues 21-229
Chain C 21–229(209 aa) Fragment:UNP residues 21-229
Chain D 21–229(209 aa) Fragment:UNP residues 21-229
Chain E 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 5 CD CADMIUM ION × 35 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 10 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain H 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 1 CD CADMIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 11 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain I 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 1 CD CADMIUM ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 12 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain J 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 1 CD CADMIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 21–229(209 aa) Fragment:UNP residues 21-229
Chain G 21–229(209 aa) Fragment:UNP residues 21-229
Chain H 21–229(209 aa) Fragment:UNP residues 21-229
Chain I 21–229(209 aa) Fragment:UNP residues 21-229
Chain J 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 5 CD CADMIUM ION × 19 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 1 CD CADMIUM ION × 8 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 1 CD CADMIUM ION × 7 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 5 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 1 CD CADMIUM ION × 7 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 6 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 1 CD CADMIUM ION × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 7 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain E 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 1 CD CADMIUM ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 8 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain F 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 1 CD CADMIUM ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTN Crystal Structure of Lymnaea stagnalis Acetylcholine Binding Protein Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 9 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain G 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 1 CD CADMIUM ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;293 K;1.5M Na acetate, 0.05M CdSO4, 0.1M HEPES-Na (pH 7.5), 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.09 Å R-free 0.262
3WTO Crystal Structure of Lymnaea stagnalis Acetylcholine-Binding Protein Q55R Mutant Complexed with Desnitro-imidacloprid Deposited 2014-04-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa) Fragment:UNP residues 21-229
Chain B 21–229(209 aa) Fragment:UNP residues 21-229
Chain C 21–229(209 aa) Fragment:UNP residues 21-229
Chain D 21–229(209 aa) Fragment:UNP residues 21-229
Chain E 21–229(209 aa) Fragment:UNP residues 21-229
Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R N2Y (2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;293 K;24-27 % PEG4000, 0.1-0.3M LiSO4, 0.1M Tris-HCl, pH 8.5, 0.5mM Desnitro-imidacloprid, VAPOR DIFFUSION, temperature 293K
Resolution 2.25 Å R-free 0.262
3ZDG Crystal Structure of Ls-AChBP complexed with carbamoylcholine analogue 3-(dimethylamino)butyl dimethylcarbamate (DMABC) Deposited 2012-11-26 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain K 20–229(210 aa)
Chain L 20–229(210 aa)
Chain M 20–229(210 aa)
Chain N 20–229(210 aa)
Chain O 20–229(210 aa)
Not recorded XRX 3-(dimethylamino)butyl dimethylcarbamate × 5 SO4 SULFATE ION × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;0.1 M TRIS (AT PH 8.5 ), 2.0 M AMMONIUM SULPHATE
Resolution 2.48 Å R-free 0.221
3ZDG Crystal Structure of Ls-AChBP complexed with carbamoylcholine analogue 3-(dimethylamino)butyl dimethylcarbamate (DMABC) Deposited 2012-11-26 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded XRX 3-(dimethylamino)butyl dimethylcarbamate × 5 SO4 SULFATE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;0.1 M TRIS (AT PH 8.5 ), 2.0 M AMMONIUM SULPHATE
Resolution 2.48 Å R-free 0.221
3ZDG Crystal Structure of Ls-AChBP complexed with carbamoylcholine analogue 3-(dimethylamino)butyl dimethylcarbamate (DMABC) Deposited 2012-11-26 Assembly 3 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded XRX 3-(dimethylamino)butyl dimethylcarbamate × 5 SO4 SULFATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;0.1 M TRIS (AT PH 8.5 ), 2.0 M AMMONIUM SULPHATE
Resolution 2.48 Å R-free 0.221
3ZDG Crystal Structure of Ls-AChBP complexed with carbamoylcholine analogue 3-(dimethylamino)butyl dimethylcarbamate (DMABC) Deposited 2012-11-26 Assembly 4 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain P 20–229(210 aa)
Chain Q 20–229(210 aa)
Chain R 20–229(210 aa)
Chain S 20–229(210 aa)
Chain T 20–229(210 aa)
Not recorded XRX 3-(dimethylamino)butyl dimethylcarbamate × 5 SO4 SULFATE ION × 3 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 1PE PENTAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;0.1 M TRIS (AT PH 8.5 ), 2.0 M AMMONIUM SULPHATE
Resolution 2.48 Å R-free 0.221
3ZDH Crystal structure of Ls-AChBP complexed with carbamoylcholine analogue N,N-dimethyl-4-(1-methyl-1H-imidazol-2-yloxy)butan-2-amine Deposited 2012-11-26 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded XRS (2R)-N,N-dimethyl-4-(1-methylimidazol-2-yl)oxy-butan-2-amine × 5 SO4 SULFATE ION × 2 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;0.1 M TRIS (PH 8.5), 2.0 M AMMONIUM SULPHATE, 2 % PEG 400
Resolution 2.19 Å R-free 0.245
3ZDH Crystal structure of Ls-AChBP complexed with carbamoylcholine analogue N,N-dimethyl-4-(1-methyl-1H-imidazol-2-yloxy)butan-2-amine Deposited 2012-11-26 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded XRS (2R)-N,N-dimethyl-4-(1-methylimidazol-2-yl)oxy-butan-2-amine × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;0.1 M TRIS (PH 8.5), 2.0 M AMMONIUM SULPHATE, 2 % PEG 400
Resolution 2.19 Å R-free 0.245
4ALX Crystal Structure of Ls-AChBP complexed with the potent nAChR antagonist DHbE Deposited 2012-03-06 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 1–229(229 aa)
Chain G 1–229(229 aa)
Chain H 1–229(229 aa)
Chain I 1–229(229 aa)
Chain J 1–229(229 aa)
Not recorded IZN (4bS,6S)-6-methoxy-1,4,6,7,9,10,12,13-octahydro-3H,5H-pyrano[4',3':3,4]pyrido[2,1-i]indol-3-one × 5 1PE PENTAETHYLENE GLYCOL × 4 MG MAGNESIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;0.1 M HEPES PH 7.5, 25% V/V PEG 400, AND 0.2 M MGCL2.
Resolution 2.30 Å R-free 0.250
4ALX Crystal Structure of Ls-AChBP complexed with the potent nAChR antagonist DHbE Deposited 2012-03-06 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–229(229 aa)
Chain B 1–229(229 aa)
Chain C 1–229(229 aa)
Chain D 1–229(229 aa)
Chain E 1–229(229 aa)
Not recorded IZN (4bS,6S)-6-methoxy-1,4,6,7,9,10,12,13-octahydro-3H,5H-pyrano[4',3':3,4]pyrido[2,1-i]indol-3-one × 5 1PE PENTAETHYLENE GLYCOL × 2 MG MAGNESIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;0.1 M HEPES PH 7.5, 25% V/V PEG 400, AND 0.2 M MGCL2.
Resolution 2.30 Å R-free 0.250
4NZB NS9283 bound to Ls-AChBP Deposited 2013-12-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded 1PE PENTAETHYLENE GLYCOL × 3 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SO4 SULFATE ION × 7 ACT ACETATE ION × 8 NSE 3-[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]benzonitrile × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1mM Tris, 0.95M (NH3)2SO4, 4% PEG 400, 0.1M NaCl, 2.5% DMSO, pH 8.0, vapor diffusion, sitting drop, temperature 293K
Resolution 2.68 Å R-free 0.240
4NZB NS9283 bound to Ls-AChBP Deposited 2013-12-11 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded 1PE PENTAETHYLENE GLYCOL × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SO4 SULFATE ION × 12 ACT ACETATE ION × 3 NSE 3-[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]benzonitrile × 3 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1mM Tris, 0.95M (NH3)2SO4, 4% PEG 400, 0.1M NaCl, 2.5% DMSO, pH 8.0, vapor diffusion, sitting drop, temperature 293K
Resolution 2.68 Å R-free 0.240
4NZB NS9283 bound to Ls-AChBP Deposited 2013-12-11 Assembly 3 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain K 20–229(210 aa)
Chain L 20–229(210 aa)
Chain M 20–229(210 aa)
Chain N 20–229(210 aa)
Chain O 20–229(210 aa)
Not recorded SO4 SULFATE ION × 1 ACT ACETATE ION × 1 NSE 3-[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]benzonitrile × 2 CL CHLORIDE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1mM Tris, 0.95M (NH3)2SO4, 4% PEG 400, 0.1M NaCl, 2.5% DMSO, pH 8.0, vapor diffusion, sitting drop, temperature 293K
Resolution 2.68 Å R-free 0.240
4QAA X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) IN COMPLEX WITH 6-(4-Methoxyphenyl)-N4-octylpyrimidine-2,4-diamine Deposited 2014-05-03 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–228(209 aa)
Chain B 20–228(209 aa)
Chain C 20–228(209 aa)
Chain D 20–228(209 aa)
Chain E 20–228(209 aa)
Not recorded KK1 6-(4-methoxyphenyl)-N~4~-octylpyrimidine-2,4-diamine × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 PO4 PHOSPHATE ION × 12 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 290K
Resolution 2.70 Å R-free 0.262
4QAA X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) IN COMPLEX WITH 6-(4-Methoxyphenyl)-N4-octylpyrimidine-2,4-diamine Deposited 2014-05-03 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–228(209 aa)
Chain G 20–228(209 aa)
Chain H 20–228(209 aa)
Chain I 20–228(209 aa)
Chain J 20–228(209 aa)
Not recorded KK1 6-(4-methoxyphenyl)-N~4~-octylpyrimidine-2,4-diamine × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 PO4 PHOSPHATE ION × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 290K
Resolution 2.70 Å R-free 0.262
4QAB X-RAY STRUCTURE of ACETYLCHOLINE BINDING PROTEIN (ACHBP) IN COMPLEX WITH 4-(MORPHOLIN-4-YL)-6-[4-(TRIFLUOROMETHYL)PHENYL]PYRIMIDIN-2-AMINE Deposited 2014-05-03 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–228(209 aa)
Chain B 20–228(209 aa)
Chain C 20–228(209 aa)
Chain D 20–228(209 aa)
Chain E 20–228(209 aa)
Not recorded KK2 4-(morpholin-4-yl)-6-[4-(trifluoromethyl)phenyl]pyrimidin-2-amine × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 PO4 PHOSPHATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 290K
Resolution 2.98 Å R-free 0.233
4QAB X-RAY STRUCTURE of ACETYLCHOLINE BINDING PROTEIN (ACHBP) IN COMPLEX WITH 4-(MORPHOLIN-4-YL)-6-[4-(TRIFLUOROMETHYL)PHENYL]PYRIMIDIN-2-AMINE Deposited 2014-05-03 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–228(209 aa)
Chain G 20–228(209 aa)
Chain H 20–228(209 aa)
Chain I 20–228(209 aa)
Chain J 20–228(209 aa)
Not recorded KK2 4-(morpholin-4-yl)-6-[4-(trifluoromethyl)phenyl]pyrimidin-2-amine × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 PO4 PHOSPHATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 290K
Resolution 2.98 Å R-free 0.233
4QAC X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) IN COMPLEX WITH 4-(4-methylpiperidin-1-yl)-6-(4-(trifluoromethyl)phenyl)pyrimidin-2-amine Deposited 2014-05-03 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–228(209 aa)
Chain B 20–228(209 aa)
Chain C 20–228(209 aa)
Chain D 20–228(209 aa)
Chain E 20–228(209 aa)
Not recorded PO4 PHOSPHATE ION × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 KK3 4-(4-methylpiperidin-1-yl)-6-[4-(trifluoromethyl)phenyl]pyrimidin-2-amine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 290K
Resolution 2.10 Å R-free 0.247
4QAC X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) IN COMPLEX WITH 4-(4-methylpiperidin-1-yl)-6-(4-(trifluoromethyl)phenyl)pyrimidin-2-amine Deposited 2014-05-03 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–228(209 aa)
Chain G 20–228(209 aa)
Chain H 20–228(209 aa)
Chain I 20–228(209 aa)
Chain J 20–228(209 aa)
Not recorded PO4 PHOSPHATE ION × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 KK3 4-(4-methylpiperidin-1-yl)-6-[4-(trifluoromethyl)phenyl]pyrimidin-2-amine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 290K
Resolution 2.10 Å R-free 0.247
4UM1 Engineered Ls-AChBP with alpha4-alpha4 binding pocket in complex with NS3573 Deposited 2014-05-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–229(229 aa)
Chain B 1–229(229 aa)
Chain C 1–229(229 aa)
Chain D 1–229(229 aa)
Chain E 1–229(229 aa)
Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES 09P 1-(5-ethoxypyridin-3-yl)-1,4-diazepane × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.1 M TRIS BASE (PH 8.0), 1-3% V/V POLYETHYLENE GLYCOL (PEG) 400 AND 1.8-2.3 M (NH4)2SO4
Resolution 2.83 Å R-free 0.231
4UM3 Engineered Ls-AChBP with alpha4-alpha4 binding pocket in complex with NS3920 Deposited 2014-05-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain P 1–229(229 aa)
Chain Q 1–229(229 aa)
Chain R 1–229(229 aa)
Chain S 1–229(229 aa)
Chain T 1–229(229 aa)
Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.1 M TRIS BASE (PH 8.0), 1-3% V/V POLYETHYLENE GLYCOL (PEG) 400 AND 1.8-2.3 M (NH4)2SO4
Resolution 2.70 Å R-free 0.244
4UM3 Engineered Ls-AChBP with alpha4-alpha4 binding pocket in complex with NS3920 Deposited 2014-05-14 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain U 1–229(229 aa)
Chain V 1–229(229 aa)
Chain W 1–229(229 aa)
Chain X 1–229(229 aa)
Chain Y 1–229(229 aa)
Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.1 M TRIS BASE (PH 8.0), 1-3% V/V POLYETHYLENE GLYCOL (PEG) 400 AND 1.8-2.3 M (NH4)2SO4
Resolution 2.70 Å R-free 0.244
4UM3 Engineered Ls-AChBP with alpha4-alpha4 binding pocket in complex with NS3920 Deposited 2014-05-14 Assembly 3 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain K 1–229(229 aa)
Chain L 1–229(229 aa)
Chain M 1–229(229 aa)
Chain N 1–229(229 aa)
Chain O 1–229(229 aa)
Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.1 M TRIS BASE (PH 8.0), 1-3% V/V POLYETHYLENE GLYCOL (PEG) 400 AND 1.8-2.3 M (NH4)2SO4
Resolution 2.70 Å R-free 0.244
4UM3 Engineered Ls-AChBP with alpha4-alpha4 binding pocket in complex with NS3920 Deposited 2014-05-14 Assembly 4 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain j 1–229(229 aa)
Chain k 1–229(229 aa)
Chain l 1–229(229 aa)
Chain m 1–229(229 aa)
Chain n 1–229(229 aa)
Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.1 M TRIS BASE (PH 8.0), 1-3% V/V POLYETHYLENE GLYCOL (PEG) 400 AND 1.8-2.3 M (NH4)2SO4
Resolution 2.70 Å R-free 0.244
4UM3 Engineered Ls-AChBP with alpha4-alpha4 binding pocket in complex with NS3920 Deposited 2014-05-14 Assembly 5 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain e 1–229(229 aa)
Chain f 1–229(229 aa)
Chain g 1–229(229 aa)
Chain h 1–229(229 aa)
Chain i 1–229(229 aa)
Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.1 M TRIS BASE (PH 8.0), 1-3% V/V POLYETHYLENE GLYCOL (PEG) 400 AND 1.8-2.3 M (NH4)2SO4
Resolution 2.70 Å R-free 0.244
4UM3 Engineered Ls-AChBP with alpha4-alpha4 binding pocket in complex with NS3920 Deposited 2014-05-14 Assembly 6 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain Z 1–229(229 aa)
Chain a 1–229(229 aa)
Chain b 1–229(229 aa)
Chain c 1–229(229 aa)
Chain d 1–229(229 aa)
Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.1 M TRIS BASE (PH 8.0), 1-3% V/V POLYETHYLENE GLYCOL (PEG) 400 AND 1.8-2.3 M (NH4)2SO4
Resolution 2.70 Å R-free 0.244
4UM3 Engineered Ls-AChBP with alpha4-alpha4 binding pocket in complex with NS3920 Deposited 2014-05-14 Assembly 7 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–229(229 aa)
Chain B 1–229(229 aa)
Chain C 1–229(229 aa)
Chain D 1–229(229 aa)
Chain E 1–229(229 aa)
Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.1 M TRIS BASE (PH 8.0), 1-3% V/V POLYETHYLENE GLYCOL (PEG) 400 AND 1.8-2.3 M (NH4)2SO4
Resolution 2.70 Å R-free 0.244
4UM3 Engineered Ls-AChBP with alpha4-alpha4 binding pocket in complex with NS3920 Deposited 2014-05-14 Assembly 8 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 1–229(229 aa)
Chain G 1–229(229 aa)
Chain H 1–229(229 aa)
Chain I 1–229(229 aa)
Chain J 1–229(229 aa)
Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES 09R 1-(6-bromopyridin-3-yl)-1,4-diazepane × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.1 M TRIS BASE (PH 8.0), 1-3% V/V POLYETHYLENE GLYCOL (PEG) 400 AND 1.8-2.3 M (NH4)2SO4
Resolution 2.70 Å R-free 0.244
4ZJT X-ray crystal structure of Lymnaea stagnalis acetylcholine binding protein (LsAChBP) in complex with 2-Thiophenylmethylene Anabaseine (2TAB) Deposited 2015-04-29 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa) Fragment:UNP residues 20-229
Chain B 20–229(210 aa) Fragment:UNP residues 20-229
Chain C 20–229(210 aa) Fragment:UNP residues 20-229
Chain D 20–229(210 aa) Fragment:UNP residues 20-229
Chain E 20–229(210 aa) Fragment:UNP residues 20-229
Not recorded PO4 PHOSPHATE ION × 5 4P6 (3E)-3-(thiophen-2-ylmethylidene)-3,4,5,6-tetrahydro-2,3'-bipyridine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.26 M ammonium phosphate, 35% glycerol
Resolution 1.85 Å R-free 0.225
4ZJT X-ray crystal structure of Lymnaea stagnalis acetylcholine binding protein (LsAChBP) in complex with 2-Thiophenylmethylene Anabaseine (2TAB) Deposited 2015-04-29 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa) Fragment:UNP residues 20-229
Chain G 20–229(210 aa) Fragment:UNP residues 20-229
Chain H 20–229(210 aa) Fragment:UNP residues 20-229
Chain I 20–229(210 aa) Fragment:UNP residues 20-229
Chain J 20–229(210 aa) Fragment:UNP residues 20-229
Not recorded PO4 PHOSPHATE ION × 5 4P6 (3E)-3-(thiophen-2-ylmethylidene)-3,4,5,6-tetrahydro-2,3'-bipyridine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.26 M ammonium phosphate, 35% glycerol
Resolution 1.85 Å R-free 0.225
4ZK1 Crystal Structure of Lymnaea stagnalis Acetylcholine-Binding Protein (LsAChBP) in Complex with 3-Pyrrolylmethylene Anabaseine Deposited 2015-04-29 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa) Fragment:UNP residues 20-229
Chain B 20–229(210 aa) Fragment:UNP residues 20-229
Chain C 20–229(210 aa) Fragment:UNP residues 20-229
Chain D 20–229(210 aa) Fragment:UNP residues 20-229
Chain E 20–229(210 aa) Fragment:UNP residues 20-229
Not recorded PO4 PHOSPHATE ION × 5 4P7 (3E)-3-(1H-pyrrol-3-ylmethylidene)-3,4,5,6-tetrahydro-2,3'-bipyridine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.26 M ammonium phosphate, 35% glycerol
Resolution 1.75 Å R-free 0.216
4ZK1 Crystal Structure of Lymnaea stagnalis Acetylcholine-Binding Protein (LsAChBP) in Complex with 3-Pyrrolylmethylene Anabaseine Deposited 2015-04-29 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa) Fragment:UNP residues 20-229
Chain G 20–229(210 aa) Fragment:UNP residues 20-229
Chain H 20–229(210 aa) Fragment:UNP residues 20-229
Chain I 20–229(210 aa) Fragment:UNP residues 20-229
Chain J 20–229(210 aa) Fragment:UNP residues 20-229
Not recorded PO4 PHOSPHATE ION × 5 4P7 (3E)-3-(1H-pyrrol-3-ylmethylidene)-3,4,5,6-tetrahydro-2,3'-bipyridine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.26 M ammonium phosphate, 35% glycerol
Resolution 1.75 Å R-free 0.216
4ZR6 Lymnaea Stagnalis Acetylcholine Binding Protein in Complex with 3-[(4E)-4-[(3-methylimidazol-4-yl)methylene]-2,3-dihydropyrrol-5-yl]pyridine Deposited 2015-05-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa) Fragment:UNP residues 20-229
Chain B 20–229(210 aa) Fragment:UNP residues 20-229
Chain C 20–229(210 aa) Fragment:UNP residues 20-229
Chain D 20–229(210 aa) Fragment:UNP residues 20-229
Chain E 20–229(210 aa) Fragment:UNP residues 20-229
Not recorded 4QW 3-{(4E)-4-[(1-methyl-1H-imidazol-5-yl)methylidene]-3,4-dihydro-2H-pyrrol-5-yl}pyridine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.6;291.15 K;0.02 M calcium chloride dihydrate, 0.1 M sodium acetate trihydrate, pH 4.6, 30% v/v MPD
Resolution 2.60 Å R-free 0.266
4ZRU X-ray crystal structure of Lymnaea stagnalis acetylcholine binding protein (Ls-AChBP) in complex with 3-[2-[(2S)-pyrrolidin-2-yl]ethynyl]pyridine (TI-5180) Deposited 2015-05-12 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa) Fragment:UNP residues 20-229
Chain B 20–229(210 aa) Fragment:UNP residues 20-229
Chain C 20–229(210 aa) Fragment:UNP residues 20-229
Chain D 20–229(210 aa) Fragment:UNP residues 20-229
Chain E 20–229(210 aa) Fragment:UNP residues 20-229
Not recorded PO4 PHOSPHATE ION × 5 TI9 3-[(2S)-pyrrolidin-2-ylethynyl]pyridine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.26 M ammonium phosphate, 35% glycerol
Resolution 1.90 Å R-free 0.204
4ZRU X-ray crystal structure of Lymnaea stagnalis acetylcholine binding protein (Ls-AChBP) in complex with 3-[2-[(2S)-pyrrolidin-2-yl]ethynyl]pyridine (TI-5180) Deposited 2015-05-12 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa) Fragment:UNP residues 20-229
Chain G 20–229(210 aa) Fragment:UNP residues 20-229
Chain H 20–229(210 aa) Fragment:UNP residues 20-229
Chain I 20–229(210 aa) Fragment:UNP residues 20-229
Chain J 20–229(210 aa) Fragment:UNP residues 20-229
Not recorded PO4 PHOSPHATE ION × 5 TI9 3-[(2S)-pyrrolidin-2-ylethynyl]pyridine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.26 M ammonium phosphate, 35% glycerol
Resolution 1.90 Å R-free 0.204
5BP0 X-ray crystal structure of Lymnaea stagnalis acetylcholine binding protein (Ls-AChBP) in complex with 5-Fluoronicotine (TI-4650) Deposited 2015-05-27 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded PO4 PHOSPHATE ION × 5 FN1 5-fluoronicotine × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.26 M ammonium phosphate, 35% glycerol
Resolution 2.40 Å R-free 0.248
5BP0 X-ray crystal structure of Lymnaea stagnalis acetylcholine binding protein (Ls-AChBP) in complex with 5-Fluoronicotine (TI-4650) Deposited 2015-05-27 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded PO4 PHOSPHATE ION × 5 FN1 5-fluoronicotine × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.26 M ammonium phosphate, 35% glycerol
Resolution 2.40 Å R-free 0.248
5J5F X-Ray Crystal Structure of Acetylcholine Binding Protein (AChBP) in Complex with N4,N4-bis[(pyridin-2-yl)methyl]-6-(thiophen-3-yl)pyrimidine-2,4-diamine Deposited 2016-04-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded PO4 PHOSPHATE ION × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 6GH N~4~,N~4~-bis[(pyridin-2-yl)methyl]-6-(thiophen-3-yl)pyrimidine-2,4-diamine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol
Resolution 2.04 Å R-free 0.202
5J5F X-Ray Crystal Structure of Acetylcholine Binding Protein (AChBP) in Complex with N4,N4-bis[(pyridin-2-yl)methyl]-6-(thiophen-3-yl)pyrimidine-2,4-diamine Deposited 2016-04-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded PO4 PHOSPHATE ION × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 6GH N~4~,N~4~-bis[(pyridin-2-yl)methyl]-6-(thiophen-3-yl)pyrimidine-2,4-diamine × 5 GOL GLYCEROL × 2 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol
Resolution 2.04 Å R-free 0.202
5J5G X-Ray Crystal Structure of Acetylcholine Binding Protein (AChBP) in Complex with 6-(4-methoxyphenyl)-N4,N4-bis[(pyridin-2-yl)methyl]pyrimidine-2,4-diamine Deposited 2016-04-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded PO4 PHOSPHATE ION × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 6GF 6-(4-methoxyphenyl)-N~4~,N~4~-bis[(pyridin-2-yl)methyl]pyrimidine-2,4-diamine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol
Resolution 2.04 Å R-free 0.209
5J5G X-Ray Crystal Structure of Acetylcholine Binding Protein (AChBP) in Complex with 6-(4-methoxyphenyl)-N4,N4-bis[(pyridin-2-yl)methyl]pyrimidine-2,4-diamine Deposited 2016-04-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded PO4 PHOSPHATE ION × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 6GF 6-(4-methoxyphenyl)-N~4~,N~4~-bis[(pyridin-2-yl)methyl]pyrimidine-2,4-diamine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol
Resolution 2.04 Å R-free 0.209
5J5H X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) IN COMPLEX WITH 6-(2-methoxyphenyl)-N4,N4-bis[(pyridin-2-yl)methyl]pyrimidine-2,4-diamine Deposited 2016-04-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded 6GK 6-(2-methoxyphenyl)-N~4~,N~4~-bis[(pyridin-2-yl)methyl]pyrimidine-2,4-diamine × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 PO4 PHOSPHATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol
Resolution 2.70 Å R-free 0.297
5J5H X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) IN COMPLEX WITH 6-(2-methoxyphenyl)-N4,N4-bis[(pyridin-2-yl)methyl]pyrimidine-2,4-diamine Deposited 2016-04-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded 6GK 6-(2-methoxyphenyl)-N~4~,N~4~-bis[(pyridin-2-yl)methyl]pyrimidine-2,4-diamine × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 PO4 PHOSPHATE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol
Resolution 2.70 Å R-free 0.297
5J5I X-Ray Crystal Structure of Acetylcholine Binding Protein (AChBP) in Complex with 4-(2-amino-6-{bis[(pyridin-2-yl)methyl]amino}pyrimidin-4-yl)phenol Deposited 2016-04-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 6GM 4-(2-amino-6-{bis[(pyridin-2-yl)methyl]amino}pyrimidin-4-yl)phenol × 5 PO4 PHOSPHATE ION × 10 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol
Resolution 2.33 Å R-free 0.250
5J5I X-Ray Crystal Structure of Acetylcholine Binding Protein (AChBP) in Complex with 4-(2-amino-6-{bis[(pyridin-2-yl)methyl]amino}pyrimidin-4-yl)phenol Deposited 2016-04-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–229(210 aa)
Chain G 20–229(210 aa)
Chain H 20–229(210 aa)
Chain I 20–229(210 aa)
Chain J 20–229(210 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 6GM 4-(2-amino-6-{bis[(pyridin-2-yl)methyl]amino}pyrimidin-4-yl)phenol × 5 PO4 PHOSPHATE ION × 11 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;290 K;0.26 M ammonium phosphate monobasic, 35% v/v glycerol
Resolution 2.33 Å R-free 0.250
5T90 Structural mechanisms for alpha-conotoxin selectivity at the human alpha3beta4 nicotinic acetylcholine receptor Deposited 2016-09-08 Assembly 1 Protein heterocomplex Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.3;293 K;0.871 M ammonium sulphate, 7.55% PEG 3350, 2-propanol 7.45% and ammonium acetate 0.1 M pH 4.3
Resolution 2.80 Å R-free 0.245
5Y2Q X-ray structure of acetylcholine binding protein (AChBP) complexed with a small molecule Deposited 2017-07-26 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa) Fragment:UNP residues 21-229
Chain B 21–229(209 aa) Fragment:UNP residues 21-229
Chain C 21–229(209 aa) Fragment:UNP residues 21-229
Chain D 21–229(209 aa) Fragment:UNP residues 21-229
Chain E 21–229(209 aa) Fragment:UNP residues 21-229
Not recorded 8L3 3-[[4-[(3,4-dichlorophenyl)methyl]piperidin-4-yl]methoxy]pyridine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;289 K;TRIS PH 8.0, AMMONIUM SULFATE
Resolution 2.36 Å R-free 0.277
7DJI Crystal structure of Lymnaea stagnalis Acetylcholine binding protein (AChBP) complexed with Paraherquamide A Deposited 2020-11-20 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 21–229(209 aa)
Chain B 21–229(209 aa)
Chain C 21–229(209 aa)
Chain D 21–229(209 aa)
Chain E 21–229(209 aa)
Not recorded H8U Paraherquamide A × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5;298 K;14.1-15.6% PEG 4000, Sodium Citrate buffer pH 5.0
Resolution 2.20 Å R-free 0.231
7N0W Rigidity of loop 1 contributes to equipotency of globular and ribbon isomers of alpha-conotoxin AusIA Deposited 2021-05-26 Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 20–224(205 aa)
Chain B 20–224(205 aa)
Chain C 20–224(205 aa)
Chain D 20–224(205 aa)
Chain E 20–224(205 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;296.15 K;0.1 M calcium acetate hydrate, 12% PEG400, 0.1M MES pH 6.0
Resolution 2.46 Å R-free 0.240
7N0Y Rigidity of loop 1 contributes to equipotency of globular and ribbon isomers of alpha-conotoxin AusIA Deposited 2021-05-26 Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 20–224(205 aa)
Chain B 20–224(205 aa)
Chain C 20–224(205 aa)
Chain D 20–224(205 aa)
Chain E 20–224(205 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;296.15 K;0.1 M calcium acetate hydrate, 18% PEG400, 0.1M MES pH 6.0
Resolution 2.58 Å R-free 0.253
7N43 Alpha-conotoxin OmIA with unusual pharmacological properties at alpha7 nicotinic receptors Deposited 2021-06-03 Assembly 1 Protein heterocomplex Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 20–229(210 aa)
Chain B 20–229(210 aa)
Chain C 20–229(210 aa)
Chain D 20–229(210 aa)
Chain E 20–229(210 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.2 M ammonium sulfate, 5% PEG4000 and 0.1M sodium acetate trihydrate pH 4.6
Resolution 2.47 Å R-free 0.212
7NDP X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL001856. Deposited 2021-02-02 Assembly 1 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–229(229 aa)
Chain B 1–229(229 aa)
Chain C 1–229(229 aa)
Chain D 1–229(229 aa)
Chain E 1–229(229 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 GOL GLYCEROL × 5 U8T 6-bromanylspiro[3~{H}-chromene-2,4'-piperidine]-4-one × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 2.00 Å R-free 0.243
7NDP X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL001856. Deposited 2021-02-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 1–229(229 aa)
Chain G 1–229(229 aa)
Chain H 1–229(229 aa)
Chain I 1–229(229 aa)
Chain J 1–229(229 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 U8T 6-bromanylspiro[3~{H}-chromene-2,4'-piperidine]-4-one × 4 SO4 SULFATE ION × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 2.00 Å R-free 0.243
7NDV X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL001888. Deposited 2021-02-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–229(229 aa)
Chain B 1–229(229 aa)
Chain C 1–229(229 aa)
Chain D 1–229(229 aa)
Chain E 1–229(229 aa)
Not recorded U8Q 4-[4-(trifluoromethyl)phenoxy]piperidine × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 1.70 Å R-free 0.233
7NDV X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL001888. Deposited 2021-02-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 1–229(229 aa)
Chain G 1–229(229 aa)
Chain H 1–229(229 aa)
Chain I 1–229(229 aa)
Chain J 1–229(229 aa)
Not recorded U8Q 4-[4-(trifluoromethyl)phenoxy]piperidine × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 1.70 Å R-free 0.233
7PD6 Crystal structure of Lymnaea stagnalis Acetylcholine-binding protein (Ls-AChBP) Q55R/M114V double mutant complexed with Sulfoxaflor Deposited 2021-08-04 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain AaA 21–229(209 aa)
Chain BaB 21–229(209 aa)
Chain CaC 21–229(209 aa)
Chain DaD 21–229(209 aa)
Chain EaE 21–229(209 aa)
Mutation:Q55R, D66N, M114V Mutation:Q55R, D66N, M114V Mutation:Q55R, D66N, M114V Mutation:Q55R, D66N, M114V Mutation:Q55R, D66N, M114V 7II Sulfoxaflor × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;14-18% PEG3350, 0.1-0.25M diammonium hydrogen citrate, 15% glycerol
Resolution 2.00 Å R-free 0.231
7PD6 Crystal structure of Lymnaea stagnalis Acetylcholine-binding protein (Ls-AChBP) Q55R/M114V double mutant complexed with Sulfoxaflor Deposited 2021-08-04 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain FaF 21–229(209 aa)
Chain GaG 21–229(209 aa)
Chain HaH 21–229(209 aa)
Chain IaI 21–229(209 aa)
Chain JJJ 21–229(209 aa)
Mutation:Q55R, D66N, M114V Mutation:Q55R, D66N, M114V Mutation:Q55R, D66N, M114V Mutation:Q55R, D66N, M114V Mutation:Q55R, D66N, M114V 7II Sulfoxaflor × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;14-18% PEG3350, 0.1-0.25M diammonium hydrogen citrate, 15% glycerol
Resolution 2.00 Å R-free 0.231
7PDB Crystal structure of Lymnaea stagnalis Acetylcholine-binding protein (Ls-AChBP) Q55R/M114V double mutant complexed with Flupyradifurone Deposited 2021-08-05 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain AaA 21–229(209 aa)
Chain BaB 21–229(209 aa)
Chain CaC 21–229(209 aa)
Chain DaD 21–229(209 aa)
Chain EaE 21–229(209 aa)
Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V 7IE Flupyradifurone × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;14-18% PEG3350, 0.1-0.25M diammonium hydrogen citrate, 15% glycerol
Resolution 2.33 Å R-free 0.256
7PDR Crystal structure of Lymnaea stagnalis Acetylcholine-binding protein (Ls-AChBP) Q55R/M114V double mutant complexed with Dichloromezotiaz Deposited 2021-08-06 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain AaA 21–229(209 aa)
Chain BaB 21–229(209 aa)
Chain CaC 21–229(209 aa)
Chain DaD 21–229(209 aa)
Chain EaE 21–229(209 aa)
Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V 7JI 3-[3,5-bis(chloranyl)phenyl]-1-[(2-chloranyl-1,3-thiazol-5-yl)methyl]-9-methyl-pyrido[1,2-a]pyrimidine-2,4-dione × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;14-18% PEG3350, 0.1-0.25M diammonium hydrogen citrate, 15% glycerol
Resolution 2.33 Å R-free 0.245
7PE5 Crystal structure of Lymnaea stagnalis Acetylcholine-binding protein (Ls-AChBP) Q55R/M114V double mutant complexed with Triflumezopyrim Deposited 2021-08-09 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain AaA 21–229(209 aa)
Chain BaB 21–229(209 aa)
Chain CaC 21–229(209 aa)
Chain DaD 21–229(209 aa)
Chain EaE 21–229(209 aa)
Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V 7OB 4-oxidanylidene-1-(pyrimidin-5-ylmethyl)-3-[3-(trifluoromethyl)phenyl]pyrido[1,2-a]pyrimidin-1-ium-2-olate × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;14-18% PEG3350, 0.1-0.25M diammonium hydrogen citrate, 15% glycerol
Resolution 2.10 Å R-free 0.229
7PE6 Crystal structure of Lymnaea stagnalis Acetylcholine-binding protein (Ls-AChBP) Q55R/M114V double mutant complexed with Flupyrimin Deposited 2021-08-09 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain AaA 21–229(209 aa)
Chain BaB 21–229(209 aa)
Chain CaC 21–229(209 aa)
Chain DaD 21–229(209 aa)
Chain EaE 21–229(209 aa)
Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V Mutation:Q55R, N66D, M114V 7OF (~{N}~{E})-~{N}-[1-[(6-chloranylpyridin-3-yl)methyl]pyridin-2-ylidene]-2,2,2-tris(fluoranyl)ethanamide × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;14-18% PEG3350, 0.1-0.25M diammonium hydrogen citrate, 15% glycerol
Resolution 2.01 Å R-free 0.227
7TXF The allosteric binding mode of alphaD-conotoxin VxXXB Deposited 2022-02-09 Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 20–224(205 aa)
Chain B 20–224(205 aa)
Chain C 20–224(205 aa)
Chain D 20–224(205 aa)
Chain E 20–224(205 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;296.15 K;0.91 M lithium chloride, 16% PEG6000 and 0.1 M MES monohydrate pH 6.4
Resolution 2.47 Å R-free 0.246
8P11 X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL003044. Deposited 2023-05-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–229(229 aa)
Chain B 1–229(229 aa)
Chain C 1–229(229 aa)
Chain D 1–229(229 aa)
Chain E 1–229(229 aa)
Not recorded CL CHLORIDE ION × 5 WD5 4-(4-chlorophenyl)piperidin-4-ol × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 1.90 Å R-free 0.244
8P11 X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL003044. Deposited 2023-05-11 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 1–229(229 aa)
Chain G 1–229(229 aa)
Chain H 1–229(229 aa)
Chain I 1–229(229 aa)
Chain J 1–229(229 aa)
Not recorded CL CHLORIDE ION × 5 WD5 4-(4-chlorophenyl)piperidin-4-ol × 3 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 1.90 Å R-free 0.244
8P1E X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL001613. Deposited 2023-05-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–229(229 aa)
Chain B 1–229(229 aa)
Chain C 1–229(229 aa)
Chain D 1–229(229 aa)
Chain E 1–229(229 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 GOL GLYCEROL × 4 SO4 SULFATE ION × 2 WD2 1-[4-(trifluoromethyl)pyridin-2-yl]piperazine × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 2.10 Å R-free 0.241
8P1E X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL001613. Deposited 2023-05-11 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 1–229(229 aa)
Chain G 1–229(229 aa)
Chain H 1–229(229 aa)
Chain I 1–229(229 aa)
Chain J 1–229(229 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 GOL GLYCEROL × 2 SO4 SULFATE ION × 1 WD2 1-[4-(trifluoromethyl)pyridin-2-yl]piperazine × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 2.10 Å R-free 0.241
8P1F X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL001909. Deposited 2023-05-12 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–229(229 aa)
Chain B 1–229(229 aa)
Chain C 1–229(229 aa)
Chain D 1–229(229 aa)
Chain E 1–229(229 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 WCW 4-azanyl-1-phenyl-piperidine-4-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 2.10 Å R-free 0.255
8P1F X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL001909. Deposited 2023-05-12 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 1–229(229 aa)
Chain G 1–229(229 aa)
Chain H 1–229(229 aa)
Chain I 1–229(229 aa)
Chain J 1–229(229 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 WCW 4-azanyl-1-phenyl-piperidine-4-carboxylic acid × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 2.10 Å R-free 0.255
8P1F X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL001909. Deposited 2023-05-12 Assembly 3 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain K 1–229(229 aa)
Chain L 1–229(229 aa)
Chain M 1–229(229 aa)
Chain N 1–229(229 aa)
Chain O 1–229(229 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 2.10 Å R-free 0.255
8P1F X-ray structure of acetylcholine-binding protein (AChBP) in complex with FL001909. Deposited 2023-05-12 Assembly 4 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain P 1–229(229 aa)
Chain Q 1–229(229 aa)
Chain R 1–229(229 aa)
Chain S 1–229(229 aa)
Chain T 1–229(229 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 2.10 Å R-free 0.255
8P22 X-ray structure of acetylcholine-binding protein (AChBP) in complex with IOTA376. Deposited 2023-05-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 20–224(205 aa)
Chain B 20–224(205 aa)
Chain C 20–224(205 aa)
Chain D 20–224(205 aa)
Chain E 20–224(205 aa)
Chain F 20–224(205 aa)
Chain G 20–224(205 aa)
Chain H 20–224(205 aa)
Chain I 20–224(205 aa)
Chain J 20–224(205 aa)
Not recorded WNO 2-[(2~{R})-1-ethylimidazolidin-2-yl]-6-pyridin-2-yl-pyridine × 9 SO4 SULFATE ION × 3 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG 3350 3% Ammonium sulphate 1.8M HEPES buffer 0.1M, pH 7.75
Resolution 2.20 Å R-free 0.304
8XSU Crystal Structure of Lymnaea stagnalis Acetylcholine-Binding Protein Q55R Mutant Complexed with Dinotefuran Deposited 2024-01-10 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 19–228(210 aa)
Chain B 19–228(210 aa)
Chain C 19–228(210 aa)
Chain D 20–225(206 aa)
Chain E 19–228(210 aa)
Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R Mutation:Q55R A1LW0 2-methyl-1-nitro-3-[(tetrahydro-3-furanyl) methyl] guanidine × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.4;293 K;PEG4000 16.5 - 18.0% , sodium citrate 0.2M
Resolution 2.63 Å R-free 0.254
8XSW Crystal Structure of Lymnaea stagnalis Acetylcholine-Binding Protein Complexed with Dinotefuran Deposited 2024-01-10 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 19–227(209 aa)
Chain B 19–227(209 aa)
Chain C 19–227(209 aa)
Chain D 19–227(209 aa)
Chain E 19–227(209 aa)
Mutation:N66D Mutation:N66D Mutation:N66D Mutation:N66D Mutation:N66D A1LW0 2-methyl-1-nitro-3-[(tetrahydro-3-furanyl) methyl] guanidine × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.7;293 K;0.2 M Na citrate, pH 5.7, 15-22% PEG3350, 1.0 mM dinotefuran,
Resolution 2.60 Å R-free 0.233
9SG3 X-ray structure of acetylcholine binding protein (AChBP) in complex with IOTA739 Deposited 2025-08-21 Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 20–225(206 aa)
Chain B 20–225(206 aa)
Chain C 20–225(206 aa)
Chain D 20–225(206 aa)
Chain E 20–225(206 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 PHN 1,10-PHENANTHROLINE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulfate 1.8 M HEPES buffer 0.1M, pH 7.75
Resolution 3.00 Å R-free 0.269
9SG3 X-ray structure of acetylcholine binding protein (AChBP) in complex with IOTA739 Deposited 2025-08-21 Assembly 2 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain F 20–225(206 aa)
Chain G 20–225(206 aa)
Chain H 20–225(206 aa)
Chain I 20–225(206 aa)
Chain J 20–225(206 aa)
Not recorded PHN 1,10-PHENANTHROLINE × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;PEG3350 3% Ammonium sulfate 1.8 M HEPES buffer 0.1M, pH 7.75
Resolution 3.00 Å R-free 0.269